Precision Biosciences (DTIL) Depreciation & Amortization (CF) (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $299000.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 24.3% year-over-year to $299000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 43.73% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, down 56.87% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $299000.0, down from $345000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for DTIL reached as high as $2.0 million in Q1 2022 and fell as low as $299000.0 in Q1 2026.
• Historically, Depreciation & Amortization (CF) has averaged $1.1 million across 5 years, with a median of $842000.0 in 2024.
• Across the five-year window, Depreciation & Amortization (CF) slumped 66.82% in 2023 and surged 31.56% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $2.0 million in 2022, then tumbled by 34.74% to $1.3 million in 2023, then slumped by 64.5% to $454000.0 in 2024, then dropped by 24.01% to $345000.0 in 2025, then retreated by 13.33% to $299000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $299000.0 in Q1 2026, $345000.0 in Q4 2025, and $309000.0 in Q3 2025.